AstraZeneca Pharma India informs about certificate

AstraZeneca Pharma India has informed that it enclosed the Certificate dated October 23, 2026 issued by Integrated Registry Management Services, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.

The above information is a part of company’s filings submitted to BSE.